Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions

Area of Science:

• Oncology
• Metabolism
• Molecular Biology

Background:

• Cachexia significantly impacts advanced cancer patients, causing muscle and adipose tissue loss.
• This condition is a primary driver of morbidity and mortality, reducing treatment tolerance and quality of life.
• Cancer cachexia remains an unmet medical need due to complex molecular mechanisms and organ crosstalk.

Purpose of the Study:

• To review the metabolic mediators of cancer cachexia.
• To elucidate their molecular functions and impact on muscle atrophy and adipose tissue browning.
• To discuss advanced therapeutic strategies for managing cancer cachexia.

Main Methods:

• Literature review focusing on molecular mechanisms of cachexia.
• Analysis of metabolic mediators and their roles in organ-specific wasting.
• Synthesis of current understanding of therapeutic approaches.

Main Results:

• Cachexia involves complex crosstalk between organs, leading to skeletal muscle wasting and adipose tissue alterations.
• Metabolic mediators play crucial roles in the progression of muscle atrophy and adipose browning.
• Recent advancements provide insights into targeted therapeutic interventions.

Conclusions:

• A comprehensive understanding of cachexia's molecular underpinnings is essential for developing effective treatments.
• Targeting metabolic pathways and organ crosstalk offers promising avenues for improving cachectic cancer patient outcomes.
• Further research into molecular mechanisms can lead to improved quality of life for affected patients.